Patent · US Active

Dual specific binding proteins directed against IL-1β and/or IL-17

US8987418B2 · kind B2 · utility

8Cited by

138References

28Claims

0Family size

Assignee

Abb Vie Inc. · US

Inventors

Tariq Ghayur · Holliston, US
Jijie Gu · Shrewsbury, US
Maria Harris · Shrewsbury, US
Carrie Goodreau · Ludlow, US
Sonal Saluja · Shrewsbury, US

Key dates

Filing date	Jul 3, 2014
Grant date	Mar 24, 2015
Priority date	—
Expiry date	Jul 3, 2034

Classification

Technology area (CPC G)Physics
CPC primaryG01N2333/545
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Engineered multivalent and multispecific binding proteins that bind IL-1β and/or IL-17 are provided, along with methods of making and uses in the prevention, diagnosis, and/or treatment of disease.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.